Literature DB >> 15033248

Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.

Andrew J Makin1, Andrew D Blann, Natali A Y Chung, Stanley H Silverman, Gregory Y H Lip.   

Abstract

BACKGROUND: Increased numbers of CD146-defined circulating endothelial cells (CECs), as are present in the peripheral blood of patients suffering acute coronary syndromes, imply injury to the endothelium. Endothelial damage can also be assessed by the measurement of plasma levels of von Willebrand factor (vWf). Increased levels of procoagulant plasma tissue factor (TF), arising from monocytes/macrophages and endothelial cells, is present in atherosclerosis. We hypothesised increased CECs in patients with ischaemic rest pain (IRP) of the lower limb due to peripheral atherosclerosis and comparable to that seen in patients with acute myocardial infarction (AMI), when compared to patients with intermittent claudication (IC) or healthy controls that would correlate with vWf and TF. PATIENTS AND METHODS: We recruited 20 patients in each of four groups: (i) IRP of the lower limb; (ii) AMI; (iii) 'stable' IC; and (iv) healthy controls. CD146-expressing CECs were measured by immumomagnetic separation and counting under a fluorescence microscope; plasma vWf and TF by ELISA.
RESULTS: In IRP, median (IQR) CEC levels were 3.5 (2.0-5.8) cells/ml, in IC were 1.1 (0.6-2.9) cells/ml, and in healthy controls were 1.0 (0.5-1.7) cells/ml (p<0.001). The levels of vWf (p=0.034) and TF (p=0.007) were also significantly different between the groups, with the highest levels in patients with IRP. Levels of CECs correlated with vWf (rs=0.4, p=0.002) and TF ( rs=0.296, p=0.021 ). In AMI, CEC levels were higher than those in IRP at 4.9 (3.6-8.4) cells/ml (p=0.0385).
CONCLUSION: This study demonstrates evidence of direct endothelial cell injury (i.e. raised CECs) in patients with IRP that correlated with vWf and TF, but that this is less severe than in AMI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033248     DOI: 10.1016/j.ehj.2003.04.001

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  25 in total

1.  Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.

Authors:  Christopher J Boos; Deirdre A Lane; Delene Kang; Patrick K Y Goon; Andrew D Blann; Gregory Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

Review 2.  Endothelial dysfunction in obstructive sleep apnea.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2007-06-15       Impact factor: 4.062

3.  Reproducibility of circulating endothelial cell enumeration and activation in children and adolescents.

Authors:  Justin R Ryder; Michael J O'Connell; Kyle D Rudser; Claudia K Fox; Anna N Solovey; Robert P Hebbel; Aaron S Kelly
Journal:  Biomark Med       Date:  2016-04-13       Impact factor: 2.851

4.  Epileptic seizures increase circulating endothelial cells in peripheral blood as early indicators of cerebral vascular damage.

Authors:  Helena Parfenova; Charles W Leffler; Dilyara Tcheranova; Shyamali Basuroy; Aliz Zimmermann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

5.  Quantifying progression and regression of thrombotic risk in experimental atherosclerosis.

Authors:  Rohun U Palekar; Andrew P Jallouk; Matthew J Goette; Junjie Chen; Jacob W Myerson; John S Allen; Antonina Akk; Lihua Yang; Yizheng Tu; Mark J Miller; Christine T N Pham; Samuel A Wickline; Hua Pan
Journal:  FASEB J       Date:  2015-04-09       Impact factor: 5.191

6.  Circulating activated endothelial cells in pediatric obesity.

Authors:  Aaron S Kelly; Robert P Hebbel; Anna N Solovey; Sarah Jane Schwarzenberg; Andrea M Metzig; Antoinette Moran; Alan R Sinaiko; David R Jacobs; Julia Steinberger
Journal:  J Pediatr       Date:  2010-06-14       Impact factor: 4.406

7.  Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.

Authors:  Rehab S El-Hagracy; Gihan M Kamal; Inas M Sabry; Abeer A Saad; Nahla F Abou El Ezz; Hesham A R Nasr
Journal:  Oman Med J       Date:  2010-07

Review 8.  Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.

Authors:  P K Y Goon; G Y H Lip; C J Boos; P S Stonelake; A D Blann
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

9.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

10.  Endothelial progenitor cells: what use for the cardiologist?

Authors:  Aurangzeb Siddique; Eduard Shantsila; Gregory Yh Lip; Chetan Varma
Journal:  J Angiogenes Res       Date:  2010-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.